Not Yet Recruiting A Multicenter Randomized Controlled Study of Interventional Treatment for Operable Stage Ⅱ-Ⅲ Non-small Cell Lung Cancer With Potential Recurrence as Minimal Residual Disease(MRD) Positive NCT06524518 Conditions DFS Locations Xuanwu Hospital — Beijing, Eijing, China View Trial Details